Unravelling the diversity of cholinesterases in the murine heart as an essential prerequisite for the use of cholinesterase inhibitors in the treatment of heart failure
Speaker:
Associate Professor A. Hrabovska (Bratislava, SK)
Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction